Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Levosimendan as Treatment of Aneurysmal SubArachnoid Hemorrhage

NCT05664191 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT05664191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05664191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Levosimendan as Treatment of Aneurysmal SubArachnoid Hemorrhage
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 2
Overall status
Completed
Start date
October 13, 2023
Completion date
April 13, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sub-arachnoid haemorrhage